Search results :

Methylphenidate

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: N06BA04, N06BA11

Side effects

Options: Show MedDRA Preferred Terms,   display only 20 labels

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33
Nervous system disorder postmarketing, 1.9% - 50% 0% - 28% x x x x x x x x x x x x x x x x
Mental disorder postmarketing, 1.2% - 46% 0% - 30% x x x x x x x x x x x x
Gastrointestinal disorder 1.7% - 44% 0.5% - 24% x x x x x x x x x x x x x x x
Decreased appetite common — 0.7% - 30% 0% - 9% x x x x x x x x x x x x x x x x x x x x
Headache postmarketing — 0.6% - 39% 11% - 19% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Malnutrition 16% - 34% 5% - 11% x x x x x x x x x x x x x x x
Dry mouth very common, 4% - 20% 3.6% - 4% x x x x x x x x x x x x x x x x x x
Mediastinal disorder 1.2% - 16% 0.3% - 8% x x x x x x x x x x x x x
Dyspepsia common, 2% - 9% 0.9% - 4% x x x x x x x x x x x x x x x x
Nausea postmarketing — 9.66% - 14.3% 2.35% - 4.9% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Abdominal pain upper 3.11% - 7.45% 3.8% x x x x x x x x x x
Anxiety postmarketing — 0.7% - 11% 0% - 2.9% x x x x x x x x x x x x x x x x x x x x x x x x x
Hyperhidrosis common, 5.1% - 5.7% 0.9% - 1.3% x x x x x x x x x
Toothache common x
Sleep disorder common x x x x x x x x
Insomnia postmarketing — 0% - 17% 0% - 7.8% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Change in blood pressure common x x x
Lethargy 4.97% x x x x x x x x x
Anorexia postmarketing, 0% - 7% 0% - 4.23% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Fatigue 4.7% 4.2% x x x x x x x x x x
Initial insomnia 2% - 5.7% 0% - 2.8% x x x x x x x x
Infestation NOS 2.2% - 5.8% 0.9% - 1.4% x x x x x x x x
Pharyngolaryngeal pain 1.2% - 7% 0.9% - 2% x x x x x x x x x x
Feeling jittery common, 1.4% x x x x x x x x x x x x x
Palpitations postmarketing — 3.1% - 4.5% 0.6% - 0.9% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Agitation common, 2.2% - 4% 0% - 0.6% x x x x x x x x x x x
Ear and labyrinth disorders 3.1% 0.9% x x x x x x x
Nasopharyngitis 2.48% - 6.83% 2.2% x x x x x x x x
Vomiting common, 1.7% - 10.2% 0% - 4.71% x x x x x x x x x x x x x x x x
Tremor common, 2.7% - 3.4% 0.5% - 0.6% x x x x x x x x x x
Diarrhoea 2.4% x x x x x x x x x
Infection postmarketing, 2.2% - 5.8% 0.9% - 1.4% x x x x x x x x x x
Body temperature increased postmarketing — 2.2% 0.9% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Hypertension 2.2% 1.6% x x x x x x x x
Upper respiratory tract infection 1.7% - 2.2% 0.9% - 1% x x x x x x x x
Excoriation postmarketing, 4% 0% x x
Motion sickness 2% 0% x
Application site reaction 2% x
Eye pain 2% 0% x
Cough common, 1.2% - 1.9% 0.3% - 1% x x x x x x x x
Dizziness postmarketing — 0% - 7.4% 0% - 5.5% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Muscle tightness 1.3% - 1.9% 0% x x x x x x
Thirst 1.8% 0.6% x x x x x
Bruxism postmarketing, 1.5% - 1.7% 0.5% - 0.6% x x x x x x x x
Connective tissue disorder 1.7% 0% x x x x x x x
Libido decreased 1.3% - 1.7% 0.5% - 0.6% x x x x x x
Vertigo 1.7% - 2% 0% - 0.3% x x x x x x x x x
Vision blurred postmarketing — 1.3% - 1.7% 0.5% - 1% x x x x x x x x x x x x
Constipation 1.4% - 1.5% 0.6% - 0.9% x x x x x x x x x
Irritability postmarketing — 0% - 11% 0% - 6.94% x x x x x x x x x x x x x x x x x x x
Affect lability 0% - 9% 0% - 2% x x x x x x x x x
Oropharyngeal pain 1.2% - 1.7% 0.9% - 1.4% x x x
Sinusitis 1.3% 1% x x x x x x
Panic attack 1.3% 0.3% x x x x
Abdominal discomfort 1.3% x x x x
Hot flush 1.3% 0.6% x x x x
Asthenia 1.2% 0% x x x x x x x
Confusional state 1% - 1.2% 0.3% - 0.5% x x x x x x x x x x
Dyspnoea 1.2% 0.6% x x x x x x x x x
Pain postmarketing, 1.2% - 1.7% 0.9% - 1.4% x x x x
Paraesthesia postmarketing, 1.2% 0% x x x x x x x x x
Tension headache 1% - 1.2% 0.3% - 0.5% x x x x x x
Tension 1.2% - 1.3% 0.3% - 0.5% x x x x x x x x
Muscle spasms 1% 0.3% x x x x
Alanine aminotransferase increased 1% 0% x x x x
Erectile dysfunction 1% 0.3% x x x x x x
Somnolence 1% x x x x x x x x
Depression 0% - 3% 0% - 0.9% x x x x x x x x x x x
Nervousness postmarketing — 0.7% - 3.1% 0.5% - 0.6% x x x x x x x x x x x x x x x x x x x x
Abdominal pain postmarketing — 0.7% - 7.14% 0% - 5.88% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Aggression postmarketing, 1.2% - 1.7% 0.5% - 0.6% x x x x x x x x x x x x x x x x x x x x x x x x x
Alopecia postmarketing, common x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Anaphylactic shock very rare, postmarketing x x x x x x x x x x x x
Anaemia very rare, postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x
Aplastic anaemia postmarketing x x
Angina pectoris postmarketing, rare x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Angioedema very rare, postmarketing x x x x x x x x x x x x
Arrhythmia postmarketing, common x x x x x x x x x x x x x x x x x x x x x x x x x x
Arthralgia postmarketing, common x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Bone disorder postmarketing x x x x x x x
Breast disorder postmarketing x x x x x x
Cerebral arteritis postmarketing x x x x x x x x x x x x x x x x x x x x x x x x
Chest pain postmarketing x x x x x x x x x x x
Contusion postmarketing x x
Sudden death postmarketing x x x x x
Dermatitis postmarketing x x x
Dermatitis exfoliative very rare, postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x
Diplopia postmarketing x x x x x x x x x
Drowsiness postmarketing, common x x x x x x x x x x x x x x x x x x x x x x x x x x
Dyskinesia postmarketing, common x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Eczema postmarketing x x x
Oedema postmarketing x
Grand mal convulsion postmarketing x x x x x x x
Erythema multiforme very rare, postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x
Rash postmarketing — 1.3% - 2% 0% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Eye disorder postmarketing, 1.7% 0% x x x x x x x x x
Hallucination postmarketing x x x x x x x x x x x
Cardiac arrest postmarketing x x x x x x x
Cardiac disorder postmarketing, 4.8% 0% x x x x x x x x x x x
Haemorrhage postmarketing x
Coma hepatic very rare, postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x
Hypersensitivity very rare, postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Hypoglycaemia postmarketing x x
Immune system disorder postmarketing x x x x x x x x x x x x
Inflammation postmarketing x
Leukopenia very rare, postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Mydriasis postmarketing x x x x x x x x x x
Neuroleptic malignant syndrome very rare, postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x
Obsessive-compulsive disorder postmarketing x x x x
Pancreatitis postmarketing x x
Pancytopenia postmarketing x x x x x x x x x x
Priapism postmarketing x x x x x x
Psychotic disorder very rare, postmarketing x x x x x x x x x x
Convulsion very rare, postmarketing x x x x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x x
Suicide postmarketing x x x
Suicide attempt postmarketing x x x
Swelling postmarketing x
Tachycardia postmarketing — 0.69% - 6% 0% - 1.9% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Supraventricular tachycardia postmarketing x x x x x x x
Thrombocytopenia very rare, postmarketing x x x x x x x x x x x x x x x x x
Tourette's disorder very rare, postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x
Ulcer postmarketing x
Erythema postmarketing x x x x x x x x x
Urticaria postmarketing, common x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Angiopathy postmarketing x x x x x x x x x
Weight increased rare x x x
Weight decreased postmarketing — 5.52% - 9.18% 0% - 3.6% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Sudden cardiac death postmarketing x x x x
Hepatic function abnormal very rare, postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x
Migraine postmarketing x x x x x x x x
Ventricular extrasystoles postmarketing x x x x x x x
Growth retardation rare x x x
Phosphatase alkaline increased postmarketing x
Accommodation disorder postmarketing, rare x x x x x x x x
Allergic contact dermatitis postmarketing x
Skin hyperpigmentation postmarketing x
Leukoderma postmarketing x
Unspecified disorder of skin and subcutaneous tissue postmarketing, 1.7% 1.4% x x x x x x x x x x
Scab postmarketing x
Fixed drug eruption postmarketing x x x x x x x
Myalgia postmarketing x x x x x x x x x x
Muscle twitching postmarketing x x x x x x x x x x x x x x x x x x x
Disorientation postmarketing x x x x x x x x
Abnormal behaviour postmarketing x x x x x x
Hallucination, auditory postmarketing x x x x x x x
Hallucination, visual postmarketing x x x x x x x
Discomfort postmarketing x
Chest discomfort postmarketing x x x x x x x
Therapeutic response decreased postmarketing x x x x x x
Hepatic enzyme increased postmarketing x x x x x x x
Skin exfoliation postmarketing x
Peripheral coldness postmarketing x x x x x
Eruption postmarketing x x x x x x x
Blood bilirubin increased postmarketing x x x x x x x
Induration postmarketing x
Papule postmarketing x
Mania postmarketing x x x x x x x x
Extrasystoles postmarketing x x x x x x x
Depressed mood very rare — 3.9% - 4.4% 1.4% - 2.6% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Warmth postmarketing x
Platelet count decreased postmarketing x x x x x x x
Hyperpyrexia postmarketing x x x x x x x x
Suicidal ideation postmarketing x x
Hyperkinesia very rare, postmarketing x x x x x x x
Bradycardia postmarketing x x x x x x x
Blood pressure increased postmarketing, 1% - 2.5% 1.9% x x x x x x x x x x x x x x x x x x
Drug effect decreased postmarketing x x x x x x
Visual disturbance postmarketing, rare x x x x x x x x x
Auricular swelling postmarketing x x x x x x x x
Reversible ischaemic neurological deficit postmarketing x x x x x
White blood cell count abnormal postmarketing x x x x x x x
Drug interaction postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Blood and lymphatic system disorders postmarketing x x x x x x x
Bullous conditions postmarketing x x x x x x x
Exfoliative conditions postmarketing x x x x x x x
Completed suicide postmarketing x x x x x x x
Blood alkaline phosphatase increased postmarketing x x x x x x
Thrombocytopenic purpura very rare, postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Pruritus NEC postmarketing x x x x x x x
Vasculitis necrotising postmarketing x x x x x x x x x x x x x x x x x x x x x x x x
Suicidal behaviour postmarketing x x x x x x
Appetite absent postmarketing x x x x x x x x x x x x x x x x x x x x x x x x
Logorrhoea postmarketing x x x
Visual impairment postmarketing x x x x x
Cerebrovascular disorder very rare x x
Cramp muscle very rare x x x
Cerebrovascular accident very rare x x x
Vasculitis very rare x x x
Hallucination, tactile very rare x x x
Choreoathetoid movements very rare x x x
Cerebral haemorrhage very rare x x x
Abscess x
Albuminuria x
Anger x x x x x x x x x
Asthma x x
Back pain x
Bronchitis x x
Neck pain x
Coma x
Conjunctivitis x x
Dehydration x
Delirium x
Dental caries x
Depersonalisation x
Diabetes mellitus x
Dysmenorrhoea x x
Ear disorder x x
Ear pain x
Ecchymosis x x
Epistaxis x x
Flushing x
Gastritis x
Gastroenteritis x
Glaucoma x x x x x x
Gynaecomastia x
Cardiac murmur x x x x x x x
Blood disorder x
Haematuria x
Haemorrhoids x
Hernia x
Herpes NOS x
Hiccups x
Hostility x
Influenza x x
Laryngitis x
Cramps of lower extremities x
Fungal infection x
Myocardial infarction x
Nail disorder x
Nasal congestion 0% - 5% 0% x x x
Nasal polyps x
Neoplasm x
Neurosis x x
Obstruction x
Otitis media x x
Pain in extremity x
Personality disorder x
Petechiae x
Pharyngitis x x
Pneumonia x
Pruritus postmarketing — 0% - 3% 0% x x x x x x x x x x x x x
Psoriasis x
Rectal disorder x
Rhinitis x x
Serum sickness x
Speech disorder x
Stereotypy x
Sweating x x
Syncope x
Attention deficit disorder x
Urinary tract disorder x
Peripheral vascular disorder x
Chills x
Body odor x
Apathy x x x
Mood swings 0% - 3% 2% x x x x x x x x x x x
Rash pustular x
Benign neoplasm x
Corneal lesion x
Accidental injury x x
Liver function test abnormal x
Reaction aggravation x
Hyperreflexia x
Skin discolouration x
Skin irritation x
Photosensitivity reaction x
Rash macular x x x x x x
Stomach ache x x x x
Malaise x x
Weight gain poor x
Chest pain exertional x
Increased appetite x x
Thinking abnormal x x x
Abnormal dreams x
Hypervigilance x x x x x x x
Euphoric mood x
Upset stomach x x x
Gastrointestinal obstruction x x x x x
Lip swelling x
Hypomania x x
Throat sore x x
Hepatobiliary disease x
Dry eye x x x x x x
Photosensitivity x
Cardiac death x
Akathisia x
Tearfulness x x x x x x
Joint sprain x
Lymphadenopathy x
Paralysis x
Cough increased x x
Ear infection x
Intoxication x
Motor tic x
Vocal tic x
Local reaction x
Libido disorder x
Sympathomimetic effect x
Sensitisation x
Drug dependence x x x x x x
Acute overdose x
Feeling sad x
Abnormal vision x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

METHYLPHENIDATE HYDROCHLORIDE / APO-METHYLPHENIDATE SR

Side effects:43
Source:Health Canada

METHYLPHENIDATE

Side effects:46
Source:FDA Structured Product Label

methylphenidate HCl tablets / Ritalin

Side effects:34
Source:FDA

METHYLPHENIDATE

Side effects:35
Source:FDA Structured Product Label

METHYLPHENIDATE

Side effects:36
Source:FDA Structured Product Label

DEXMETHYLPHENIDATE

Side effects:41
Source:FDA Structured Product Label

METHYLPHENIDATE

Side effects:43
Source:FDA Structured Product Label

methylphenidate

Side effects:45
Source:FDA Structured Product Label

methylphenidate

Side effects:50
Source:FDA Structured Product Label

METHYLPHENIDATE

Side effects:51
Source:FDA Structured Product Label

METHYLPHENIDATE

Side effects:51
Source:FDA Structured Product Label

methylphenidate

Side effects:52
Source:FDA Structured Product Label

DEXMETHYLPHENIDATE

Side effects:53
Source:FDA Structured Product Label

DEXMETHYLPHENIDATE

Side effects:57
Source:FDA Structured Product Label

DEXMETHYLPHENIDATE

Side effects:58
Source:FDA Structured Product Label

METHYLPHENIDATE HYDROCHLORIDE / RITALIN 10MG

Side effects:78
Source:Health Canada

METHYLPHENIDATE

Side effects:89
Source:FDA Structured Product Label

methylphenidate / RITALIN10 / RITALINLA

Side effects:125
Source:medicines.org.au

METHYLPHENIDATE

Side effects:78
Source:FDA Structured Product Label

methylphenidate HCl / Concerta

Side effects:124
Source:FDA

METHYLPHENIDATE HYDROCHLORIDE / CONCERTA

Side effects:124
Source:FDA

METHYLPHENIDATE

Side effects:133
Source:FDA Structured Product Label

METHYLPHENIDATE

Side effects:135
Source:FDA Structured Product Label

Methylphenidate

Side effects:135
Source:FDA Structured Product Label

METHYLPHENIDATE HYDROCHLORIDE / BIPHENTIN

Side effects:113
Source:Health Canada

METHYLPHENIDATE HYDROCHLORIDE / CONCERTA

Side effects:144
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label